peptide companies tirzepatide Tirzepatide-RUO 30MG Half-truth. That's the honest answer

Weight loss results vary significantly by specific medication and dose: Semaglutide 2.4 mg (Wegovy): Clinical trials (STEP program) showed average weight reductions of 1517% at 68 weeks Tirzepatide (Zepbound): SURMOUNT trials demonstrated weight reductions of 1522% at 72 weeks, with results varying between populations with and without diabetes Liraglutide 3 mg (Saxenda): Typically produces 510% weight loss over 56 weeks The rate of weight loss is not linear

CAUTION: Formulated for adults and children four years and older

Example: 10mg+10mg blend, choose 10mg as the quantity to get the individual peptide amount

It happens because GLP-1 receptor agonists like tirzepatide create sustained appetite suppression and delayed gastric emptying, leading to caloric deficits large enough to mobilise subcutaneous fat stores across the body, including the face

Freeze-thaw cycles can cause peptide aggregation and loss of potency